Preventing and controlling invasive fungal infections in the U.S.
RFA-CK-23-001, Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases
This program builds better national tracking, tests, and prevention steps to help people who get serious fungal infections.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11172222 on NIH RePORTER |
What this research studies
From your perspective, this program will collect information from hospitals across the country to find who gets invasive fungal infections and why. It will link patient information to a central specimen repository so new diagnostic tests can be developed and checked against real patient samples. The team will use that data to spot risk factors, measure outcomes, and try public health interventions to reduce infections. The work is coordinated by the Mycoses Study Group at the University of Alabama at Birmingham with projects started in sequence over the award period.
Who could benefit from this research
Good fit: People with confirmed or suspected invasive fungal infections and those at high risk (for example, transplant recipients, people on chemotherapy or long-term immunosuppression, or others with severe unexplained infections) would be most likely to qualify.
Not a fit: People without invasive or serious fungal infections—such as those with only mild or superficial fungal conditions—or those outside participating U.S. centers may not benefit directly from this program.
Why it matters
Potential benefit: If successful, the work could lead to faster, more accurate diagnosis, improved prevention measures, and better treatment outcomes for people with invasive fungal infections.
How similar studies have performed: Surveillance networks and diagnostic research in fungal disease have helped before, but gaps remain, so this program builds on prior successes while testing new approaches.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Pappas, Peter George — University of Alabama at Birmingham
- Study coordinator: Pappas, Peter George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.